Remote ischemic preconditioning prevents high‐altitude cerebral edema by enhancing glucose metabolic reprogramming
Rongrong Han,
No information about this author
Xiaoyan Yang,
No information about this author
Xunming Ji
No information about this author
et al.
CNS Neuroscience & Therapeutics,
Journal Year:
2024,
Volume and Issue:
30(9)
Published: Sept. 1, 2024
Abstract
Aims
Incidence
of
acute
mountain
sickness
(AMS)
ranges
from
40%–90%,
with
high‐altitude
cerebral
edema
(HACE)
representing
a
life‐threatening
end
stage
severe
AMS.
However,
practical
and
convenient
preventive
strategies
for
HACE
are
lacking.
Remote
ischemic
preconditioning
(RIPC)
has
demonstrated
effects
on
ischemia‐
or
hypoxia‐induced
cardiovascular
cerebrovascular
diseases.
This
study
aimed
to
investigate
the
potential
molecular
mechanism
application
RIPC
in
preventing
onset.
Methods
A
hypobaric
hypoxia
chamber
was
used
simulate
environment
7000
meters.
Metabolomics
metabolic
flux
analysis
were
employed
assay
metabolite
levels.
Transcriptomics
quantitative
real‐time
PCR
(q‐PCR)
gene
expression
Immunofluorescence
staining
performed
neurons
label
cellular
proteins.
The
fluorescent
probes
Mito‐Dendra2,
iATPSnFR1.0,
CMTMRos
observe
mitochondria,
ATP,
membrane
cultured
neurons,
respectively.
TUNEL
detect
quantify
apoptotic
cell
death.
Hematoxylin
eosin
(H&E)
utilized
analyze
pathological
changes,
such
as
tissue
swelling
cortex
samples.
Rotarod
test
assess
motor
coordination
balance
rats.
Oxygen–glucose
deprivation
(OGD)
cells
an
vitro
model
hypoglycemia
induced
by
animal
experiments.
Results
We
revealed
causative
perturbation
glucose
metabolism
brain
preceding
edema.
Ischemic
treatment
significantly
reprograms
metabolism,
ameliorating
apoptosis
energy
deprivation.
Notably,
improves
mitochondrial
ATP
production
through
enhanced
glucose‐coupled
metabolism.
In
vivo
studies
confirm
that
alleviates
edema,
reduces
hypoxia,
dysfunction
resulting
Conclusions
Our
elucidates
basis
pathogenesis.
provides
new
strategy
reprogramming
highlighting
targeting
neuroprotective
interventions
neurological
diseases
caused
ischemia
hypoxia.
Language: Английский
Closing the loop: Autonomous intelligent control for hypoxia pre-acclimatization and high-altitude health management
Dawei Shi,
No information about this author
Jing Chen,
No information about this author
Miao Li
No information about this author
et al.
National Science Review,
Journal Year:
2025,
Volume and Issue:
12(5)
Published: March 7, 2025
Hypobaric
hypoxia
at
high
altitudes
threatens
the
health
of
high-altitude
residents.
The
development
effective
methods
to
guarantee
safety
frequent
human
activities
in
locations
is
therefore
needed.
Pre-acclimatization
sea
level
an
approach
mitigate
subsequent
altitude
sickness
for
rapid
ascent,
which
offers
a
viable
substitute
on-site
acclimatization,
minimizes
associated
risks
that
are
linked
prolonged
exposure
environments
and
can
be
personalized
individual
hypoxic
responses.
Another
critical
aspect
prevent
long-term
physical
damage
management
altitudes,
enabled
by
emerging
technologies
wearable
sensors,
Internet
Medical
Things
artificial
intelligence.
In
this
review,
we
outline
progress
pre-acclimatization
management,
as
well
understanding
physiological
mechanisms
under
hypoxia,
highlighting
important
role
played
sensors
closed-loop
control
systems
developing
intelligent
solutions.
We
also
discuss
challenges
prospects
deploying
autonomous
monitoring
management.
Language: Английский
Multi-omics analysis reveals phenylalanine enhance mitochondrial function and hypoxic endurance via LKB1/AMPK activation
Yi‐Long Wu,
No information about this author
Yi Ma,
No information about this author
Qiang Li
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Oct. 10, 2024
Many
studies
have
focused
on
the
effects
of
small
molecules,
such
as
amino
acids,
metabolism
under
hypoxia.
Recent
findings
indicated
that
phenylalanine
levels
were
markedly
elevated
in
adaptation
to
chronic
This
raises
possibility
treatment
could
improve
hypoxic
endurance.
However,
importance
hypoxia-regulated
is
still
unclear.
study
investigates
role
hypoxia
using
a
zebrafish
model
and
multi-omics
analysis.
We
found
phenylalanine-related
metabolic
pathways
are
significantly
up-regulated
hypoxia,
contributing
enhanced
Phenylalanine
reduced
ROS
levels,
improved
mitochondrial
oxygen
consumption
rate
(OCR),
extracellular
acidification
(ECAR)
cells.
Western
blotting
revealed
increased
uptake
via
L-type
transporters
(LAT1),
activating
LKB1/AMPK
signaling
pathway.
activation
peroxisome
proliferator-activated
receptor
gamma
coactivator-1
alpha
(PGC-1α)
Bcl-2/Bax
ratio,
while
down-regulating
uncoupling
protein
2
(UCP2),
thereby
improving
function
first
comprehensive
analysis
demonstrate
phenylalanine's
crucial
adaptation,
providing
insights
for
development
anti-hypoxic
drugs.
Language: Английский
Th1/Th2 Immune Imbalance in the Spleen of Mice Induced by Hypobaric Hypoxia Stimulation and Therapeutic Intervention of Astragaloside IV
Rong Gao,
No information about this author
Zhenhui Wu,
No information about this author
Wanyun Dang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2584 - 2584
Published: March 13, 2025
This
study
aims
to
establish
a
hypobaric
hypoxia-induced
immune
injury
model
and
investigate
the
intervention
therapeutic
effects
of
Astragaloside
IV
(AS-IV).
simulated
hypoxia
stimulation
in
mice
at
an
altitude
7000
m
on
plateau
for
1,
3,
5,
7
days.
HE
staining
transcriptomic
analysis
were
performed
mouse
spleens.
In
addition,
AS-IV
was
selected
prevention
treatment,
validated
by
flow
cytometry,
ELISA,
Q-PCR.
The
results
showed
that
under
hypoxic
conditions
5
days,
peripheral
blood
lymphocytes
decreased,
CD45+
cells,
CD3+
T
CD3+CD4+
CD4+/CD8+
cell
ratio
spleen
all
decreased.
can
significantly
alleviate
pathological
damage
spleen,
decrease
serum
levels
IL-2
IL-6,
increase
IL-4
IL-10,
raise
cells
while
increasing
CD4+IFN-γ+cells
reducing
ROS
apoptosis
content
relevant
mRNA
Th1/Th2
pathway.
summary,
simulating
days
stable
model,
effectively
injury.
Language: Английский
RIPC improves myocardial injury by promoting mitochondrial protection via the PGC-1α/Nrf2 pathway
Journal of Biological Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108476 - 108476
Published: April 1, 2025
Myocardial
infarction
(MI)
is
a
common
condition
with
high
morbidity
and
mortality
rates.
Remote
ischemic
preconditioning
(RIPC)
activates
the
endogenous
protective
mechanisms
by
promoting
tolerance
mitigating
subsequent
damage
caused
fatal
ischemia.
Maintaining
mitochondrial
function
imperative
for
prevention
of
myocardial
The
current
study
aims
to
evaluate
therapeutic
effects
RIPC
on
MI
focus
involved
in
function.
In
our
study,
patients
who
underwent
coronary
angiography
were
randomly
assigned
either
group
(n
=
20)
or
control
20).
intervention
was
administered
preoperatively
inflating
blood
pressure
cuff
upper
arm
200
mmHg
four
cycles
5
min
each,
interspersed
5-min
reperfusion
intervals.
process
alleviated
injury
among
participants,
accompanied
significant
elevation
serum
concentrations
PGC-1α
Nrf2
levels
serum.
In-vitro
studies
showed
that
can
protect
cardiomyocytes
against
preserving
morphology,
maintaining
membrane
integrity,
reducing
oxidative
stress.
In-vivo
experimental
findings
illustrated
mitigated
structural
mice
augmenting
function,
leading
cardiac
protection,
as
evidenced
improved
reduced
infarct
size.
Moreover,
abolished
upon
silencing
PGC-1α.
Collectively,
results
indicated
PGC-1α/Nrf2
signaling
pathway
rescue
during
insult,
suggesting
promising
strategy
preventing
ischemia
injury.
Language: Английский
Hypoxia reduces mouse urine output via HIF1α–mediated up–regulation of renal AQP1
Kidney Diseases,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 15
Published: Oct. 22, 2024
Patients
with
acute
mountain
sickness
(AMS)
due
to
hypoxia
at
high
altitudes
often
exhibit
abnormal
water
metabolism.
Hypoxia-inducible
factors
(HIFs)
are
major
regulators
of
adaptive
responses
hypoxia.
As
transcription
factors,
HIFs
involved
in
the
regulation
erythropoiesis,
iron
metabolism,
angiogenesis,
energy
and
cell
survival
by
promoting
transcriptional
expression
hundreds
target
genes.
Roxadustat,
a
novel
drug
for
treatment
anemia
associated
chronic
kidney
disease
(CKD),
acts
inhibiting
degradation
increase
their
protein
levels.
However,
clinical
use
roxadustat
is
frequently
peripheral
edema,
suggesting
involvement
regulating
body's
balance
possibly
modulating
reabsorption
kidney.
Language: Английский